Compare TGTX & WTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TGTX | WTS |
|---|---|---|
| Founded | 1993 | 1874 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | 10.0B |
| IPO Year | 2008 | 1994 |
| Metric | TGTX | WTS |
|---|---|---|
| Price | $55.16 | $388.58 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 6 |
| Target Price | $49.80 | ★ $335.00 |
| AVG Volume (30 Days) | ★ 2.8M | 382.6K |
| Earning Date | 05-04-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.70% |
| EPS Growth | ★ 1746.67 | 17.03 |
| EPS | 0.12 | ★ 2.97 |
| Revenue | $2,785,000.00 | ★ $2,438,500,000.00 |
| Revenue This Year | $49.08 | $11.17 |
| Revenue Next Year | $26.69 | $5.72 |
| P/E Ratio | $457.67 | ★ $131.91 |
| Revenue Growth | N/A | ★ 8.27 |
| 52 Week Low | $25.37 | $242.77 |
| 52 Week High | $57.38 | $394.54 |
| Indicator | TGTX | WTS |
|---|---|---|
| Relative Strength Index (RSI) | 77.96 | 73.97 |
| Support Level | $28.57 | $267.54 |
| Resistance Level | $57.38 | N/A |
| Average True Range (ATR) | 2.39 | 11.72 |
| MACD | 0.24 | 4.80 |
| Stochastic Oscillator | 81.53 | 94.32 |
TG Therapeutics Inc is a fully integrated, commercial-stage biotechnology company focused on acquiring, developing, and commercializing novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features.
Watts Water Technologies Inc is a U.S.-based company that provides safety, energy efficiency, and water conservation products. Its product portfolio includes residential and commercial flow control products, which are sold for plumbing and hot water applications; HVAC and gas products, including commercial boilers, water heaters, heating solutions, etc.; drainage and water reuse products, including drainage products and engineered rainwater-harvesting solutions; and water quality products, including point-of-use and point-of-entry water filtration, conditioning, and scale prevention systems. Its products are marketed through brands like Watts, Apex, Bradley, Nexa, and others. Geographically, the company derives its key revenue from the Americas, followed by Europe and the APMEA region.